Archive - July 19, 2015

For the last few years, a research team at Baylor University has been studying the possible link between the use of chloroquine (Aralen) and a reduced risk of breast cancer.  RPCV women have been the targeted demographic. Now, this phase of the study is ending, the use of the questionnaire is discontinued, and the methodology is being revised. The following is a review of the project. On Thursday, May 8th 2014, I posted the following on http://old.peacecorpsworldwide.org/pc-public-records/page/6/ I have edited the post. This post does include a link describing the unusual sampling method that the study attempted to use. Baylor  University has received a to study the potential of chloroquine to reduce the risk of breast cancer. The study is funded by a grant from the Congressionally Directed Medical Research Projects and administered by the U.S. Department of Defense. (Corrected: July 21, 2015) Chloroquine was taken to guard against malaria. Aralen is the name I knew for . . .